-
SIDEROS Trial of Puldysa in Duchenne Patients Completes Enrollment
Santhera said a next step for its Phase 3 trial of Puldysa in aiding lung function in DMD patients on glucocorticoids is independent analysis of efficacy. Click here to read more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.